The company notified customers that product availability will be affected by a one- to two- week lag time as the changes are processed through the distribution network, according to a Nov. 26 news release from the company.
Baxter also outlined plans to gradually increase allocations over the next several weeks, with the goal of reaching 100% allocation for several IV product codes by the end of 2024. The company has also said it will provide updates on its allocation plans in mid-December and again at year’s end.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
